295 related articles for article (PubMed ID: 1271696)
1. [Blood coagulation and fibrinolysis in women receiving estrogen, gestagen and estrogen-gestagen-contraceptives (author's transl)].
Lechner K; Hartmann E; Schneider WH; Spona J; Matt K
Klin Wochenschr; 1976 May; 54(9):431-8. PubMed ID: 1271696
[TBL] [Abstract][Full Text] [Related]
2. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
[TBL] [Abstract][Full Text] [Related]
3. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
4. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
[TBL] [Abstract][Full Text] [Related]
5. Studies on plasma coagulation and fibrinolysis during oral contraception of various types with special reference to cold activation of factor VII.
Gjonnaess H; Fagerhol MK
Scand J Haematol; 1974; 12(3):232-40. PubMed ID: 4831827
[TBL] [Abstract][Full Text] [Related]
6. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives, anti-thrombin III and fibrinolytic activity in Africans.
Greig HB
Acta Haematol; 1977; 58(3):138-44. PubMed ID: 409028
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
Winkler UH; Schindler AE; Endrikat J; Düsterberg B
Contraception; 1996 Feb; 53(2):75-84. PubMed ID: 8838483
[TBL] [Abstract][Full Text] [Related]
10. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
Petersen KR; Sidelmann J; Skouby SO; Jespersen J
Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
[TBL] [Abstract][Full Text] [Related]
11. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system.
Spona J; Feichtinger W; Kindermann C; Schneider B; Mellinger U; Walter F; Moore C; Gräser T
Contraception; 1997 Aug; 56(2):67-75. PubMed ID: 9315414
[TBL] [Abstract][Full Text] [Related]
13. Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid.
Jespersen J; Petersen KR; Skouby SO
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):396-403. PubMed ID: 2196812
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives and blood coagulation.
Bonnar J; Sabra AM
J Reprod Med; 1986 Jun; 31(6 Suppl):551-6. PubMed ID: 2941571
[TBL] [Abstract][Full Text] [Related]
15. Coagulation effects of oral contraception.
Bonnar J
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1042-8. PubMed ID: 2960241
[TBL] [Abstract][Full Text] [Related]
16. Lipids and blood coagulation studies in women using steroidal hormones for contraception.
Hashmi JA; Kazi AB; Kazi A; Ali N
J Pak Med Assoc (1951); 1972 Aug; 22(8):218-25. PubMed ID: 12305803
[TBL] [Abstract][Full Text] [Related]
17. Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet function.
Prasad RN; Koh S; Ratnam SS
Contraception; 1989 Apr; 39(4):369-83. PubMed ID: 2524360
[TBL] [Abstract][Full Text] [Related]
18. A norgestimate-containing oral contraceptive: review of clinical studies.
Kafrissen ME
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1196-202. PubMed ID: 1415446
[TBL] [Abstract][Full Text] [Related]
19. Anti-estrogens and plasma proteins. II. Contraceptive drugs and gestagens.
Barbosa J; Seal US; Doe RP
J Clin Endocrinol Metab; 1973 Apr; 36(4):706-14. PubMed ID: 4119677
[TBL] [Abstract][Full Text] [Related]
20. Adrenocortical function of patients using oral contraceptives.
Kauppila A; Järvinen PA; Ylöstalo P; Reinilä M
Acta Obstet Gynecol Scand; 1974; 53(2):155-9. PubMed ID: 4362662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]